These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23634887)

  • 21. Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.
    Sivars L; Landin D; Haeggblom L; Tertipis N; Grün N; Bersani C; Marklund L; Ghaderi M; Näsman A; Ramqvist T; Nordfors C; Munck-Wikland E; Tani E; Dalianis T
    Head Neck; 2017 Mar; 39(3):419-426. PubMed ID: 27898186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
    Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-Catenin Expression in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16 and Human Papillomavirus in situ Hybridization.
    Nwanze J; Cohen C; Schmitt AC; Siddiqui MT
    Acta Cytol; 2015; 59(6):479-84. PubMed ID: 26849661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Papillomavirus DNA Detection by Droplet Digital PCR in Formalin-Fixed Paraffin-Embedded Tumor Tissue from Oropharyngeal Squamous Cell Carcinoma Patients.
    Schiavetto CM; de Abreu PM; von Zeidler SV; de Jesus LM; Carvalho RS; Cirino MT; Carloni AC; Oliveira C; Scapulatempo-Neto C; de Almeida GC; de Menezes NS; Carvalho AL; Reis RM; de Carvalho AC
    Mol Diagn Ther; 2021 Jan; 25(1):59-70. PubMed ID: 33245553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea: use of G1 cycle markers as new prognosticators.
    Park WS; Ryu J; Cho KH; Choi MK; Moon SH; Yun T; Chun BS; Lee GK; Ahn HJ; Lee JH; Vermeer P; Jung YS
    Head Neck; 2012 Oct; 34(10):1408-17. PubMed ID: 22052559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of HPV prevalence in HNSCC patients with regard to regional and socioeconomic factors.
    Krupar R; Hartl M; Wirsching K; Dietmaier W; Strutz J; Hofstaedter F
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1737-45. PubMed ID: 24065189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice.
    Thavaraj S; Stokes A; Guerra E; Bible J; Halligan E; Long A; Okpokam A; Sloan P; Odell E; Robinson M
    J Clin Pathol; 2011 Apr; 64(4):308-12. PubMed ID: 21345874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009).
    Rodrigo JP; Heideman DA; García-Pedrero JM; Fresno MF; Brakenhoff RH; Díaz Molina JP; Snijders PJ; Hermsen MA
    Int J Cancer; 2014 Jan; 134(2):487-92. PubMed ID: 23824638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
    Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics of Japanese oropharyngeal squamous cell carcinoma positive for human papillomavirus infection.
    Nomura F; Sugimoto T; Kitagaki K; Ito T; Kawachi H; Eishi Y; Watanabe K; Igaue M; Shimizu N; Tomita M; Kitamura K; Kishimoto S
    Acta Otolaryngol; 2014 Dec; 134(12):1265-74. PubMed ID: 25399886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression.
    Ramshankar V; Soundara VT; Shyamsundar V; Ramani P; Krishnamurthy A
    Asian Pac J Cancer Prev; 2014; 15(19):8351-9. PubMed ID: 25339028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-risk HPV DNA status and p16 (INK4a) expression as prognostic markers in patients with squamous cell cancer of oral cavity and oropharynx.
    Śnietura M; Jaworska M; Pigłowski W; Goraj-Zając A; Woźniak G; Lange D
    Pol J Pathol; 2010; 61(3):133-9. PubMed ID: 21225495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic accuracy of p16
    Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
    Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that alpha-9 human papillomavirus infections are a major etiologic factor for oropharyngeal carcinoma in black South Africans.
    Paquette C; Evans MF; Meer SS; Rajendran V; Adamson CS; Cooper K
    Head Neck Pathol; 2013 Dec; 7(4):361-72. PubMed ID: 23797844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
    Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
    Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of high-risk HPV DNA PCR, p16
    Simoens C; Gheit T; Ridder R; Gorbaslieva I; Holzinger D; Lucas E; Rehm S; Vermeulen P; Lammens M; Vanderveken OM; Kumar RV; Gangane N; Caniglia A; Maffini F; Rubio MBL; Anantharaman D; Chiocca S; Brennan P; Pillai MR; Sankaranarayanan R; Bogers J; Pawlita M; Tommasino M; Arbyn M;
    BMC Infect Dis; 2022 Aug; 22(1):676. PubMed ID: 35933382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary.
    McDowell LJ; Young RJ; Johnston ML; Tan TJ; Kleid S; Liu CS; Bressel M; Estall V; Rischin D; Solomon B; Corry J
    Cancer; 2016 Apr; 122(8):1201-8. PubMed ID: 26881928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators--a pilot study.
    Bussu F; Sali M; Gallus R; Petrone G; Zannoni GF; Autorino R; Dinapoli N; Santangelo R; Vellone VG; Graziani C; Miccichè F; Almadori G; Galli J; Delogu G; Sanguinetti M; Rindi G; Tommasino M; Valentini V; Paludetti G
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1115-1120. PubMed ID: 25035216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
    Weinberger PM; Yu Z; Haffty BG; Kowalski D; Harigopal M; Brandsma J; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
    J Clin Oncol; 2006 Feb; 24(5):736-47. PubMed ID: 16401683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.